Contribution of Endogenous Glucagon-Like Peptide 1 to Glucose Metabolism After Roux-en-Y Gastric Bypass

The contribution of elevated glucagon-like peptide 1 (GLP-1) to postprandial glucose metabolism after Roux-en-Y gastric bypass (RYGB) has been the subject of uncertainty. We used exendin-9,39, a competitive antagonist of GLP-1, to examine glucose metabolism, islet hormone secretion, and gastrointest...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Meera, Law, Jennie H., Micheletto, Francesco, Sathananthan, Matheni, Dalla Man, Chiara, Cobelli, Claudio, Rizza, Robert A., Camilleri, Michael, Zinsmeister, Alan R., Vella, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2014
Materias:
Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968439/
https://www.ncbi.nlm.nih.gov/pubmed/24089513
http://dx.doi.org/10.2337/db13-0954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968439/
https://www.ncbi.nlm.nih.gov/pubmed/24089513
http://dx.doi.org/10.2337/db13-0954

Ejemplares similares